Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058430 · ClinicalTrials.gov registry record · NA
SaliPen Human Factors Study for OTC Labeling
A NA study of Xerostomia, sponsored by Saliwell.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05058430 is a NA study of Xerostomia that has completed, run by Saliwell. The registered enrollment target is 24 participants, below the 93-participant average among 13 other Xerostomia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05058430, a NA study of Xerostomia, has completed, sponsored by Saliwell.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This Human Factors Validation Testing will assess user interactions to verify the capability of potential users to assess if the study product fits their needs and if they can use it correctly based on the provided Information For User (IFU)? More specifically, this is a non-comparative case series study and is subdivided into two major parts. Those parts are: 1. Phase I: aimed at testing if, based on the IFU, the potential subjects can decide whether the study product is or is not appropriate to treat their condition and, 2. Phase II: aimed at assessing whether the users can use the study product correctly without counseling by a health care provider.
Conditions Studied
Interventions
- DEVICE Electrical salivary stimulator system assigned to subjects with xerostomia
- DEVICE No Electrical salivary stimulator system assigned to subjects without xerostomia
Study Locations (1)
Indiana
- Indiana University School of Dentistry, Oral Health Research Institute - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2021-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058430
The ClinicalTrials.gov registry entry for NCT05058430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 13 other Xerostomia trials with a reported enrollment target (74% lower). The listed sponsor is Saliwell, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 2 interventions - of which Electrical salivary stimulator system assigned to subjects with xerostomia is the first listed.
NCT05058430 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05058430 about?
NCT05058430 is a clinical study titled "SaliPen Human Factors Study for OTC Labeling". This Human Factors Validation Testing will assess user interactions to verify the capability of potential users to assess if the study product fits their needs and if they can use it correctly based on the provided Information For User (IFU)? More specifically, this is a non-comparative case series...
What is the current status of trial NCT05058430?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-09-16. Estimated completion is 2021-11-18.
What conditions does trial NCT05058430 study?
This clinical trial studies the following conditions: Xerostomia.
What interventions are being tested in trial NCT05058430?
The interventions under investigation include: Electrical salivary stimulator system assigned to subjects with xerostomia (DEVICE), No Electrical salivary stimulator system assigned to subjects without xerostomia (DEVICE).
Who is sponsoring clinical trial NCT05058430?
This trial is sponsored by Saliwell, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05058430 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
COMPLETED · NA
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
COMPLETED · NA
-
Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray
COMPLETED · NA
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
RECRUITING · Phase 1
-
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.